According to reports by CNBC TV18, the investment firm Carlyle Group is in advanced stages for acquisition of Granules India for around $1 billion. Carlyle is likely to buy promoter shares of Granules India. Carlyle recently bought a small stake in Piramal Pharma and acquired global veterinary giant Sequent Scientists. However Granules India stayed muted to CNBC TV18 comment.
Carlyle Group in talks to acquire Granules India
1 min read
Tags:
Srushti Vaidya
Srushti Vaidya is a mass media student from Ramnarian Ruia Autonomous College, Mumbai. She holds interest in politics and wants to pursue her carrer in journalism. Contact her at vaidyasrushti19@gmail.com